MEDICINE DETAILS
Kaftrio
Active ingredient: Elexacaftor Tezacaftor Ivacaftor
The EMA record for Kaftrio distinguishes film-coated tablet and granule presentations containing elexacaftor, tezacaftor and ivacaftor. Strength order, dosage form and pack count must be checked together.
NEXT STEP
Choose the strength and pack
✓ If you are unsure, choose “I do not know”.
These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.
ABOUT THIS MEDICINE
What is Kaftrio used for?
Kaftrio (elexacaftor/tezacaftor/ivacaftor) is a medication used in combination with ivacaftor 150 mg tablets for people with cystic fibrosis (CF) aged 12 years and older with at least one copy of the F508del mutation.
This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.
RECORDED PRODUCT PROFILE
Kaftrio identity, dosage form and pack information.
The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.
OFFICIAL RECORD SUMMARY
Product details checked against regulatory sources
The EMA record for Kaftrio distinguishes film-coated tablet and granule presentations containing elexacaftor, tezacaftor and ivacaftor. Strength order, dosage form and pack count must be checked together.
- ✓37.5 mg/25 mg/50 mg film-coated tablets — 56 tablets
- ✓75 mg/50 mg/100 mg film-coated tablets — 56 tablets
- ✓60 mg/40 mg/80 mg granules — 28 sachets
- ✓75 mg/50 mg/100 mg granules — 28 sachets
- ✓The U.S. brand is Trikafta; do not treat a U.S. record as a Kaftrio pack record
Presentations can differ by jurisdiction and authorisation. This list is not a use or dosing recommendation.
Recorded strength and pack options
Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.
-
37.5 mg/25 mg/50 mg film-coated tablets · 56 tablets Catalogue organisation: Vertex Pharmaceuticals (Germany) GmbH
-
60 mg/40 mg/80 mg granules · 28 sachets Catalogue organisation: Vertex Pharmaceuticals (Germany) GmbH
-
75 mg/50 mg/100 mg film-coated tablets · 56 tablets Catalogue organisation: Vertex Pharmaceuticals (Germany) GmbH
-
75 mg/50 mg/100 mg granules · 28 sachets Catalogue organisation: Vertex Pharmaceuticals (Germany) GmbH
OFFICIAL SOURCES
Check the Kaftrio record at an official source.
Search for “Kaftrio” or “Elexacaftor Tezacaftor Ivacaftor”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.
OFFICIAL EXTERNAL SOURCE
European Medicines Agency (EMA)
Search medicines evaluated by EMA by brand name or active substance. EMA also links to national registers for nationally authorised products.
↗ OFFICIAL EXTERNAL SOURCE Drugs@FDASearch FDA-approved human drug records by brand name or active ingredient, including current labelling where available.
↗ PRODUCT-SPECIFIC OFFICIAL RECORD EMA — Kaftrio EPAREuropean public assessment and authorised presentation information for Kaftrio.
↗SERVICE BOUNDARY
Information checking and independent enquiry support for Kaftrio.
OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.
Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.
CLEAR ANSWERS
Frequently asked questions about Kaftrio
01What is Kaftrio?＋
This directory record associates the brand name Kaftrio with the active ingredient Elexacaftor Tezacaftor Ivacaftor. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.
02Which Kaftrio strengths and packs are recorded?＋
The catalogue currently shows: 37.5 mg/25 mg/50 mg film-coated tablets · 56 tablets; 60 mg/40 mg/80 mg granules · 28 sachets; 75 mg/50 mg/100 mg film-coated tablets · 56 tablets; 75 mg/50 mg/100 mg granules · 28 sachets. Check the complete strength, dosage form and pack description against the prescription and medicine box.
03Who manufactures Kaftrio?＋
Catalogue records currently name: Vertex Pharmaceuticals (Germany) GmbH. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.
04Do the listed options confirm stock or access?＋
No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.
05What affects a possible estimated medicine cost for Kaftrio?＋
A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Kaftrio, payment request, stock guarantee or binding offer.
06Can I buy Kaftrio from this website?＋
No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.